Diabetes & CV Disease

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
67:29

Philips

PAD and CLI State of the Art: What Is the Role of Telemedicine? How to Improve Patients' QoL?

FEATURING Chris Lesar, Craig Walker, Sreekumar Madassery, Timothy Yates
  • 344 views
  • July 7, 2021
  • 2
30:46

Scripps Health

Diabetes Treatment in Patients With CVD and HF in 2021: SGLT-2 Inhibitors, GLP1-Receptor Agonists and Other Emerging Therapies

FEATURING Daniel Einhorn
  • 238 views
  • July 7, 2021
  • 2
18:00

Scripps Health

New Developments in Treatment of Heart Failure With Low EF and Pulmonary HTN: Sacubitril/Valsartan, SGLT-2i, PDE5i and Others

FEATURING Thomas Heywood
  • 314 views
  • July 8, 2021
  • 1
21:12

National Lipid Association

Health Disparities Within the Diverse Hispanic Population: Underlying Causes for Health Disparities and Prevention Strategies

FEATURING Eduardo Sanchez
  • 29 views
  • July 9, 2021
16:05

Piedmont Heart Institute

Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women

FEATURING Denise Reedus, Barbara Conlon
  • 42 views
  • July 13, 2021
12:10

Hertzel Gerstein

AMPLITUDE: A GLP-1 Receptor Agonist CV Outcomes Trial

  • 225 views
  • July 14, 2021
  • 1
08:03

Jennifer Green

Highlights From ADA 2021: The Pros and Cons of Starting SGLT2 Inhibitors or GLP1-RAs in the Hospital to Reduce the Risk of Adverse CV or Kidney Outcomes

  • 359 views
  • July 14, 2021
  • 3
18:17

Brendon Neuen

2021 ADA Highlights: CREDENCE Trial: Lessons Learned From the First Trial in Nearly Two Decades in Regard to Improving Cardiorenal Outcomes in Diabetic Kidney Disease

  • 787 views
  • July 14, 2021
  • 4
15:30

Eliot Brinton

2021 ADA Highlights: Substantial Cardiovascular Risk Reduction With Icosapent Ethyl Regardless of BMI or Diabetes Status - REDUCE-IT BMI

  • 793 views
  • July 14, 2021
  • 1
12:37

David Wheeler

2021 ADA Highlights: Landmark DAPA-CKD Trial in Kidney Disease: Extending the Benefits of SGLT2 Inhibitors to and Beyond Diabetic Neuropathy

  • 370 views
  • July 14, 2021
  • 4
16:15

Paul Franks

2021 ADA Highlights: Debate on Precision Nutrition - Take Home Messages

  • 140 views
  • July 14, 2021
18:47

Becky Sulik

2021 ADA Highlights: Real-World Perspective on Carbohydrate Counting for Bolus Insulin Decision-Making

  • 901 views
  • July 14, 2021
  • 5
25:23

Hope Warshaw

2021 ADA Highlights: Diabetes Diets From the 1980's to 2021: Prescribed Macronutrient Percentages to Person-Centered Approaches and Beyond

  • 146 views
  • July 14, 2021
16:44

Francesco Giorgino

2021 ADA Highlights: SURPASS-3: Tirzepatide or Basal Insulin Degludec as Injectible Treatment After Oral Antihyperglycemic Medication

  • 702 views
  • July 14, 2021
11:24

Francesco Giorgino

2021 ADA Highlights: SURPASS Program: Change in HbA1C From Baseline

  • 906 views
  • July 14, 2021
  • 4
41:15

Jane Reusch

2021 ADA General Highlights: GRADE Study, GIP/GLP-1 Receptor Agonists, Mental Health + Population Considerations in Diabetes, and More

FEATURING Cecilia Low Wang
  • 192 views
  • July 14, 2021
  • 1
07:26

Complex Coronary Cases

Revascularization in Patients with SIHD, Multivessel CAD, ACS and LM Disease: PCI or CABG?

FEATURING Jennifer S. Lawton
  • 314 views
  • July 14, 2021
  • 2
21:59

Melinda Maryniuk

2021 ADA Highlights: Diabetes Diets Since the Discovery of Insulin: 1921-1970's Starvation Diets to Exchange System

  • 184 views
  • July 16, 2021
  • 2
24:05

Jackie Boucher

2021 ADA Highlights: Lipids and Carbohydrates - Food Sources, Quality, Costs, and Beyond

  • 77 views
  • July 16, 2021
15:58

Karen Elkind-Hirsch

2021 ADA Highlights: New Approaches for the Treatment of Polycystic Ovarian Syndrome Using GLP1s and DPP4s

  • 644 views
  • July 21, 2021
  • 3
14:52

Richard Pratley

Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study

  • 432 views
  • July 23, 2021
  • 7
10:40

Diana Isaacs

ADA 2021 Highlights: Type 2 Diabetes

  • 455 views
  • July 23, 2021
  • 2
11:47

Teja Kompala

ADA 2021 Highlights: Continuous Glucose Monitoring Showing Reduction in A1C and Hospitalization for Hypoglycemia. How Can CGM Be Integrated for Use in the Primary Care Setting?

  • 215 views
  • July 23, 2021
  • 1
59:00

Meeting Pearls

Management of Diabetes in Children: Distinguishing Between Types of Diabetes & Treatment Approaches

FEATURING Siri Atma Greeley
  • 569 views
  • July 29, 2021
  • 4
26:13

Cardiovascular Atherosclerosis: Prediction, Prevention and Management

Update on Inflammation and Novel Biomarkers for Atherosclerosis

FEATURING Douglas Triffon
  • 382 views
  • August 11, 2021
  • 2

Diabetes & CV Disease

All Topics: